Tag Archives: Troyen A. Brennan

Posted on by

CVS Health recognized with 2018 PBMI Excellence Award for Care Management Strategies

WOONSOCKET, R.I., 2018-Mar-09 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (March 7, 2018) that the Pharmacy Benefit Management Institute (PBMI) awarded the company the 2018 PBMI Excellence Award for Care Management Strategies. The award recognizes the ScriptPath Prescription Schedule, which was developed by CVS Health to help provide a consolidated view of a patient’s current CVS Pharmacy prescriptions with an easy-to-understand schedule showing how and when to take each medication.

“We are pleased to be recognized with this award for our industry-leading work to bring the ScriptPath Prescription Schedule to patients as we help them on their path to better health,” said Troyen A. Brennan, MD Chief Medical Officer, CVS Health. “For CVS Health, this award validates our efforts to develop innovative programs that improve patient engagement and medication adherence, better manage chronic diseases like diabetes and help clients keep their health care costs down.”

The average American adult fills nine prescriptions annually, with people older than 65 filling an average of 20 prescriptions a year. Unfortunately, approximately half of patients report being confused about how and when to take their medications, contributing to the 50 percent of patients with chronic conditions who stop taking their medications within the first year of diagnosis. Further, studies show a 5.7 percent to 6.8 percent decrease in adherence for each dose added to a medication regimen. For patients who are not optimally adherent to prescribed therapies, hospital readmission rates increase by as much as 69 percent, which can result in annual U.S. health care costs between $100 to $300 billion.

The ScriptPath Prescription Schedule offers patients with chronic conditions and complex regimens a personalized prescription schedule with easy-to-understand icons explaining which medication to take, when it should be taken and how much should be taken in each dose. It is designed to improve patient understanding and safety and help simplify how patients take their medications. The schedule is generated by our proprietary Clinical Engine, a robust scientific system created by CVS Pharmacy, which automatically reviews all of a patient’s current CVS Pharmacy prescription information and prescribers’ instructions. Using clinical data, the Clinical Engine slots a patient’s medications into up to four dosing times per day morning, midday, evening and bedtime and recommends dosing times for each medication based on the most effective times of day for the medications to be taken. Deborah Adler, a designer known for her past work on Target’s ClearRx prescription packaging system and the inventor and lead designer of the new ScriptPath system, worked with the CVS Health team to develop the easy-to-understand icons and an intuitive layout for each of the ScriptPath offerings.

In addition to the Prescription Schedule, CVS Pharmacy is in the process of rolling out the ScriptPath Prescription Label and Prescription Overview to all stores nationwide this spring. This will extend the use of the easy-to-understand design of the Prescription Schedule to the label on the prescription bottle as well as the prescription bag tag.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,800 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 94 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact: 
Christina Beckerman
CVS Health
401-770-8868

SOURCE: CVS Health

Posted on by

CVS Health survey: majority of Americans agree that the health care system is in need of reform

WOONSOCKET, R.I., 2017-Dec-01 — /EPR Retail News/ — Results of a new national survey from CVS Health (NYSE: CVS) released today (November 30, 2017) found that over half (56 percent) of Americans say the U.S. health care system does not work well for them, while overwhelming majorities agree the system is in need of reform (73 percent) and is currently too politicized (69 percent).

The State of Health Care in the United States.
Of those Americans frustrated by the current state of U.S. health care, 65 percent say it is too expensive, and the affordability of health care, health insurance and prescription drugs top the list of Americans’ most urgent concerns.

The results of the national survey of 2,201 adults, conducted online by Morning Consult on behalf of CVS Health in October 2017 and released at the Forbes Health Care Summit, also found that more Americans (41 percent) believe health care in the U.S. has generally gotten worse rather than improved over the past five years. However, when it comes to their personal experience, a plurality say their own health care has largely not changed, and a larger share of Americans say it has gotten better (28 percent) than who say it has gotten worse (23 percent).

Despite generally negative views of health care in the United States, a vast majority of insured respondents (83 percent) say they are somewhat or very satisfied with their health plans. However, nearly a third report that they did not have a choice in the health plan that was offered to them.

At the same time, respondents of the survey are hopeful about the health care system’s future state, particularly for the next generation of Americans. This sentiment is particularly strong among American parents of whom 52 percent say they are optimistic their children will have better health care than they did at their age. They point to innovation as the reason, with 65 percent who say advances in health care will make lives safer and 66 percent who say advances will make lives longer.

However, the survey reveals limits to Americans’ optimism as a skeptical public questions whether effective health care reform will eliminate regulatory barriers to innovation and put patients first. According to the survey, a plurality of Americans (45 percent) feel there is too much regulation in the way of innovation in health care. Furthermore, three out of five Americans say decisions made in health care put the bottom line ahead of patients, whereas only one in five say that either decisions put patients first or they are at least considered equally with the bottom line.

“While we see significant frustration in this poll with the cost and quality of healthcare, there is a sense of hope among Americans about the future,” said CVS Health Chief Medical Officer Troyen A. Brennan, M.D., M.P.H. “These findings underscore a challenging set of pain points in the system which should serve as a catalyst for all players in health care patients, providers, payors and policymakers to work together to pursue the necessary reforms and innovations that improve quality and affordability and make a complex system easier to navigate for a more empowered health care consumer.”

The full set of survey results is available at www.cvshealth.com/stateofhealthcare.

Survey Methodology

This survey was conducted online within the United States between October 19-23, 2017 among 2,201 adults aged 18+ by Morning Consult on behalf of CVS Health. Results from the survey have a margin of error of 2%.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Joe Goode
401-770-9820
Joseph.Goode@CVSHealth.com

SOURCE: CVS Health

Posted on by

CVS Health to provide Real-time benefit information to help eliminate potential dispensing delays and improve patient outcomes

WOONSOCKET, R.I., 2017-Nov-29 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (November 28, 2017) that its pharmacy benefits manager (PBM), CVS Caremark, will begin providing real-time visibility to member-specific medication costs and available lower-cost therapeutic alternatives at the point of prescribing and at the pharmacy. This enhanced visibility to the patient’s benefit across all points of care can help eliminate potential dispensing delays, improve patient outcomes through increased medication adherence and lower costs for members and payors.

“Patients often do not find out that the medication they were prescribed is not covered or has higher than expected out-of-pocket costs until they go to the pharmacy to pick up their prescription, which can result in patients not filling a prescription, non-adherence and, ultimately, higher downstream health care costs,” said Troyen A. Brennan, MD, Executive Vice President and Chief Medical Officer of CVS Health. “Making detailed, real-time benefit information available for our PBM members and their health care team, whether it’s the doctor or the pharmacist, can help streamline the patient experience and improve health outcomes while also lowering costs for both the patient and the payor.”

Through visibility to “real-time benefits,” prescribers can see specific benefit information for patients supported by CVS Caremark integrated directly into their e-prescribing workflow. Even before they prescribe a drug, prescribers will be able to see the cost of the drug based on the patient’s coverage, including the patient’s remaining deductible, when applicable, and will be able to review up to five clinically appropriate branded alternatives or therapeutically equivalent generic medications specific to the patient’s formulary coverage. Prescribers will also have visibility to requirements, such as prior authorization or step therapy, enabling them to immediately submit an electronic prior authorization request. In addition, pharmacists at all retail pharmacies within the CVS Caremark network will have visibility to the same list of clinically appropriate formulary alternatives provided to the prescriber, and beginning in early 2018, CVS Caremark members will be able to find lower-cost alternatives within the Check Drug Cost tool on Caremark.com.

At CVS Pharmacy, this information will be integrated directly into the pharmacist’s existing workflow, making it easy for them to engage CVS Caremark members about potentially lower-cost alternatives, based on the members’ specific formulary coverage. CVS pharmacists will also be able to easily request a prescription change from the prescriber when needed with a simple one-step process. Beginning in early 2018, as part of the company’s ongoing, enterprise-wide focus on helping patients save money, CVS pharmacists will also be able to see the associated out-of-pocket costs for CVS Caremark members. This will help ensure alignment with the member’s plan design and enable them to access the lowest cost medications within their benefit. For those members for whom drug cost is still a concern, the CVS pharmacist will also be able to share additional cost savings opportunities such as prescription discounts, when available.

“Across the CVS Health enterprise, we are focused on providing patients with the most convenient access to affordable medications, and this innovation enables us to provide our PBM members and their health care providers with direct, easy access to real-time benefit information throughout the health care continuum whether they are at their physician’s office or at the pharmacy,” said Jonathan Roberts, Executive Vice President and Chief Operating Officer of CVS Health. “No one else provides this level of member-specific actionable drug benefit information across so many points of care, which can help simplify and streamline the process of getting a patient on the most appropriate and affordable therapy and increase member engagement and satisfaction with their care.”

Medication cost can be a significant factor when a patient is deciding whether or not to fill a prescription. Yet, research shows that patients often feel they do not have adequate information about the use of formularies or the drugs covered by their plan. In addition, when required, the manual prior authorization process to gain necessary approvals for a specific drug from both the insurer and prescriber can be time-consuming for prescribers, patients and pharmacists. In fact, approximately 80 percent of physicians said manual prior authorization requests require extra work, rework and follow up, which can also delay the start of an important therapy or result in poor compliance. Altogether, this can result in medication non-adherence, which can lead to poor health outcomes and is estimated to cost the U.S. health care system nearly $300 billion each year.

Real-time benefit information is enabled through functionality from Surescripts and is available to any provider using an electronic health record system enabled with real-time benefits and electronic prior authorization. Real-time benefits further build on CVS Health’s use of electronic health records, to support MinuteClinic nurse practitioners and CVS Specialty’s care management programs.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com/.

Contacts:

Christine Cramer
CVS Health
(401) 770-3317
christine.cramer@cvshealth.com

Christina Beckerman
CVS Health
(401) 770-8868
christina.beckerman@cvshealth.com

SOURCE: CVS Health

Posted on by

CVS Health and Epic announce initiative to help lower drug costs for patients

WOONSOCKET, R.I., 2017-Oct-17 — /EPR Retail News/ — CVS Health (NYSE: CVS) and Epic today (October 16, 2017) announced a strategic initiative to help lower drug costs for patients and improve outcomes by providing prescribers with expanded visibility to lower cost alternatives through enhanced analytics and data sharing. CVS Health will use Epic’s Healthy Planet population health and analytics platform to generate insights surrounding dispensing patterns and behaviors around medication adherence.

The collaboration will bolster prescription decision-making for patients and their care teams, including physicians, pharmacists and health insurers. Real-time benefit information and facilitated, point-of-prescribing electronic prior authorization will help improve and simplify patient access to necessary medications and ensure their prescribers are aware of prescription insurance formulary status and less expensive alternatives as appropriate.

“This collaboration with Epic will enable us to continue to drive leading edge technology innovation beyond the pharmacy to the full health care system,” said Stephen Gold, Chief Information Officer, CVS Health. “Together, our two companies will also examine opportunities to streamline and improve data sharing and linkages across the health care system to enhance communication and connectivity among patients, their physicians, the pharmacy and health insurers.”

“At CVS Health we recognize that EHRs offer health care providers easier and more comprehensive access to their patients’ information than ever before,” said Troyen A. Brennan, M.D., Chief Medical Officer, CVS Health. “This new relationship will help us further expand how we work with Epic and providers on their EHR system to develop meaningful tools and programs that will ultimately help us take even better care of the patients we support.”

CVS Health currently works with Epic, the most widely used EHR, to support the company’s MinuteClinic nurse practitioners and CVS Specialty’s care management programs.

Through this new strategic relationship CVS Health and Epic will explore a number of new areas including:

  • Prescription Drug Savings: Collaboration around real-time benefit information and facilitated, point-of-prescribing electronic prior authorization to help inform patients and prescribers in real time about covered drugs that are clinically effective and available at the lowest out-of-pocket cost for the patient;
  • Improved Prescribing Decisions: Development of a comprehensive clinical database to enhance medication counseling and help optimize medication selection for CVS Health patients;
  • Shared Care Plan for Pharmacists: Improve pharmacist access to clinical information and allow contribution to the care plan to improve continuity of care;
  • Digital Front Store Capabilities: Creation of a digital front store to enable inclusion of purchases of over-the-counter medications and durable medical equipment into the patient’s electronic health record.

“CVS Health is one of the leaders in using data to dissolve domain silos, while offering new sources of intelligence and expertise that can better inform care delivery, reduce administrative overhead, and lower costs for patients,” said Alan Hutchison, Epic Vice President of Population Health.

“Working in collaboration with CVS Health allows for enhanced and efficient data integration and decision support for clinicians while relieving administrative burden,” said Gregory Rosencrance, M.D., chairman of Cleveland Clinic Medicine Institute. “These promising advances put the patient at the center of care while improving the cost and quality of care they receive.” CVS Health is a member of Cleveland Clinic’s clinically integrated network and Quality Alliance.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Contact:

Christine Cramer
(401) 770-3317
christine.cramer@cvshealth.com

Joe Goode
(401) 770-9820
joseph.goode@cvshealth.com

SOURCE: CVS Health

Posted on by

New research underscores need for continued monitoring of pharmaceutical marketing practices to help drive down overall drug spending

WOONSOCKET, R.I., 2017-May-03 — /EPR Retail News/ — CVS Health (NYSE: CVS) today (May 2, 2017) lauded findings from new research showing that policies limiting pharmaceutical sales activities at academic medical centers resulted in a modest, but significant change in prescribing behavior. The research, published today in an issue of the Journal of the American Medical Association (JAMA) focused on conflicts of interest in medicine, found that when these policies were implemented there was a decrease in prescribing of drugs detailed by pharmaceutical sales representatives and an increase in prescribing of non-detailed drugs, the majority of which (more than 95 percent) were generics. This research underscores the need for continued monitoring of pharmaceutical marketing practices and the ongoing adoption of programs and policies that increase the availability and utilization of generic drugs in the marketplace, as a way to help drive down overall drug spending.

“Physician visits from drug sales representatives help keep expensive brand name drugs top-of-mind for physicians, which can ultimately impact their prescribing behavior,” said Troyen A. Brennan, M.D., Chief Medical Officer of CVS Health and a study co-author. “At a time when the cost of prescription drugs and pharmacy care is under increased scrutiny, this new data shows that policies to restrict pharmaceutical sales calls can lead to increased prescribing of equally effective, less expensive generic drugs.”

Researchers at the UCLA Medical Center and Carnegie Mellon University compared prescribing practices of physicians at academic medical centers in five states before and after implementation of restrictive pharmaceutical detailing policies over a six-year period. De-identified pharmacy claims data was provided by CVS Health for eight drug classes used to treat common, chronic conditions for which lower-cost generics are available, including high blood pressure and high cholesterol. The study found that when more restrictive policies to limit on-site pharmaceutical marketing activity were adopted by the medical centers, there was a decrease in market share of 1.67 percentage points for brand name drugs previously detailed by pharmaceutical representatives and an increase in market share of lower cost, mostly generic, alternatives by 0.84 percentage points across the majority of drug classes.

“This research is instructive as we look at ways to help curb overall health care spending and points to a tremendous opportunity for increasing utilization of generic medicines as a measured approach to help control overall pharmacy spend,” added Dr. Brennan. “In fact, when high cost brand name drugs are prescribed more often, research suggests that overall health care spending can rise exponentially, much of which is likely avoidable.”

Clinically equivalent and often more cost effective than their brand name counterparts, generic drugs help control pharmacy spend and increase access to important therapies for patients who could be deterred by the high cost of some branded drugs. In fact, according to the Association for Accessible Medicines, the use of generic drugs produces annual savings in excess of $200 billion. Additionally, in a separate editorial also published in today’s issue of JAMA, authors cite research showing that the overuse of high cost brand name medications resulted in about $73 billion in costs to the U.S. health care system between 2010-2012, about a third of which was paid for by patients.

Pharmacy benefit managers (PBMs), including CVS Caremark, the PBM of CVS Health, also help drive value for payors and patients with formularies that favor generic drugs. In fact, in 2016, generic drugs had the largest deflationary impact on CVS Caremark drug trend the year-over-year growth in prescription spending due to higher dispensing rates combined with lower overall inflation and falling prices for most generics. In addition, increasing drug competition by addressing the backlog of generic medicines awaiting FDA approval and promoting policies that do not delay market entry of generic drugs will help increase the number of lower cost generic drugs available in the marketplace.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its nearly 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contacts:

Christine Cramer
CVS Health
(401) 770-3317
christine.cramer@cvshealth.com

Christina Beckerman
CVS Health
(401) 770-8868
christina.beckerman@cvshealth.com

SOURCE: CVS Health

Posted on by

CVS Health Research Institute study emphasizes the role a private retailer can play in restricting access to tobacco

WOONSOCKET, R.I., 2017-Feb-17 — /EPR Retail News/ — Newly published research from the CVS Health (NYSE: CVS) Research Institute emphasizes the role a private retailer can play in restricting access to tobacco and improving public health. The study, published online today (Feb. 16, 2017 ) in the American Journal of Public Health, showed that the Company’s decision to remove tobacco from all CVS Pharmacy stores reduced the number of cigarette purchases across all retail settings with an even greater impact on those who bought cigarettes exclusively at CVS Pharmacy. The research confirms and expands upon initial impact data released on the one-year anniversary of the Company’s removal of cigarettes and other tobacco products from its retail stores.

“When we removed tobacco from our shelves, a significant number of our customers simply stopped buying and hopefully smoking cigarettes altogether instead of just altering their cigarette purchasing habits,” said Troyen A. Brennan, M.D., Chief Medical Officer of CVS Health and an author of the study. “This research proves that our decision had a powerful public health impact by disrupting access to cigarettes and helping more of our customers on their path to better health.”

The study assessed the impact of CVS Health’s discontinuation of tobacco sales by analyzing data from a nationally representative survey of consumers’ cigarette purchasing behavior at drug, food, big box, dollar, convenience and gas station retailers prior to and one year following the Company’s decision. While the Company’s decision reduced cigarette purchases across all retail settings, those who purchased cigarettes exclusively at CVS Pharmacy were 38 percent more likely to stop buying cigarettes, and those who purchased three or more packs per month were more than twice as likely to stop buying cigarettes altogether.

“CVS Health’s decision to end tobacco sales has had a substantial and measurable impact on improving our nation’s health,” said Matthew L. Myers, President of the Campaign for Tobacco-Free Kids. “These newly published results make it increasingly untenable for responsible retailers especially those that provide health care services to continue selling tobacco products. We also urge parents and other consumers concerned about health to patronize retailers that don’t sell tobacco products, such as those on our website, www.ShopTobaccoFree.org.”

Following CVS Health’s decision to exit tobacco in 2014, the company has extended its commitment to helping people lead tobacco-free lives through increased smoking cessation resources and a focus on youth tobacco use and prevention. In 2016, CVS Health announced Be The First, a five-year, $50 million initiative to help deliver the first tobacco-free generation. With support and funding through CVS Health and the CVS Health Foundation, Be The First supports comprehensive education, advocacy, tobacco control and healthy behavior programming delivered in concert with a group of national partner organizations.

“Tobacco use, especially among our youth, is one of the most pressing public health issues that we face today,” said Eileen Howard Boone, Senior Vice President of Corporate Social Responsibility and Philanthropy at CVS Health, and President of the CVS Health Foundation. “While smoking rates among children and adults have declined over the past decade, approximately 36.5 million adults still smoke and 3,200 people under age 18 smoke their first cigarette every day. Reducing tobacco use continues to be a public health priority, which we are committed to addressing.”

Smoking is the leading cause of preventable morbidity and mortality in the United States, accounting for more than 480,000 deaths each year, $170 billion in medical costs and $156 billion in lost productivity. For more information on CVS Health’s commitment to tobacco-free living, visit www.CVSHealth.com/BeTheFirst.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Contacts:

Christina Beckerman
CVS Health
(401) 770-8868
christina.beckerman@cvshealth.com

Mary Alfieri
CVS Health
(401) 770-8078
mary.alfieri@cvshealth.com

SOURCE: CVS Health

Posted on by

Transform Diabetes Care™: CVS Health new program to improve health outcomes and lower pharmacy costs

WOONSOCKET, R.I., 2016-Dec-14 — /EPR Retail News/ — CVS Health (NYSE: CVS) today ( December 13, 2016) introduced Transform Diabetes Care™, a new program available to help the company’s pharmacy benefit management (PBM) clients improve the health outcomes of their members, lower pharmacy costs through aggressive trend management and decrease medical costs by improving medication adherence, A1C control and lifestyle management. This program, which will be available in early 2017, emphasizes tailored support for members with diabetes and incorporates both clinical care and cost management solutions, including a single-digit client trend guarantee for medicines in the antidiabetic category. In fact, participating clients could save between $3,000 to $5,000 per year for each member who successfully improves control of their diabetes.

“The Transform Diabetes Care program focuses on three key components to help improve outcomes and reduce overall health care spend in diabetes: medication adherence, A1C control and lifestyle management,” said Troyen A. Brennan, MD, Chief Medical Officer of CVS Health. “What’s unique about this program is that at CVS Health we are able to marshal resources across our enterprise and provide a high level of personalized support and care via multiple touch points. What makes our face-to-face counseling and education at our more than 9,600 pharmacy locations and more than 1,100 MinuteClinic locations so effective is that it happens when patients are already thinking about their health.”

The Transform Diabetes Care program uses advanced analytics to identify unique improvement opportunities for enrolled members and leverages the company’s Health Engagement Engine to enable more effective outreach by identifying and prompting personalized counseling opportunities. Enrolled members will receive highly personalized support and coaching to help improve medication adherence, better track and control A1C levels and support healthy lifestyle behaviors through CVS Health consumer touch points. These interventions will be delivered to enrolled members, at no extra cost, either in person at CVS Pharmacy, or by telephone, and members will also receive free comprehensive diabetes visits at MinuteClinic locations at no out-of-pocket cost, including A1C checks. In addition, members will be offered a connected glucometer, which will share their blood glucose levels with a pharmacist-led team via a health cloud, enabling the team to identify potential issues and intervene with one-on-one coaching. Members also have access to digital tools within the CVS Pharmacy mobile app, such as medication refill reminders and the ability to refill a prescription via two-way text messaging, to help reduce the complexity of daily disease management.

“In 2016 antidiabetic drugs were the leading driver of gross costs for our clients,” said Jonathan Roberts, President of CVS Caremark. “The Transform Diabetes Care program will enable us to help our clients manage the unsustainable increases in the cost of diabetes care by maximizing the value and effectiveness of our engagement with patients to improve clinical outcomes, while also employing strategic approaches to actively manage and control costs.”

Clients enrolled in the Transform Diabetes Care program will have a year-over-year drug trend guarantee in the single digits for the antidiabetic drug category, which will vary based on the plan population’s demographics and current spend profile. In addition, the program has a managed pharmacy network for drugs to treat diabetes, which includes all CVS Pharmacy locations and CVS Caremark Mail Service Pharmacy. This will help simplify medication refills, improve coordination of care with the member’s primary care providers and help members stay engaged with their therapy and additional clinical services offered by the program.

The Transform Diabetes Care program, the first in a new suite of Transform Care programs focused on managing costly, chronic conditions, expands the suite of diabetes programs and services already provided by CVS Health. Studies have shown that through better lifestyle management, medication adherence and control of A1C, health can improve and medical costs can be significantly reduced. In fact, the CVS Health Pharmacy Advisor Counseling program has shown a nearly 10 percent increase in optimal medication adherence for enrolled members with diabetes.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contacts:

Christine Cramer
CVS Health
(401) 770-3317
christine.cramer@cvshealth.com

Christina Beckerman
CVS Health
(401) 770-8868
christina.beckerman@cvshealth.com

SOURCE: CVS Health

Posted on by

American Cancer Society and CVS Health Foundation initiative support college and university campuses go smoke- and tobacco-free

ATLANTA, 2016-Nov-14 — /EPR Retail News/ — The American Cancer Society and the CVS Health Foundation today awarded grants to 20 U.S. colleges and universities as part of their Tobacco-Free Generation Campus Initiative (TFGCI), a $3.6 million multi-year program intended to accelerate and expand the adoption and implementation of 100 percent smoke- and tobacco-free campus policies. The announcement coincides this week with the American Cancer Society Great American Smokeout.

Experience the interactive Multimedia News Release here: http://www.multivu.com/players/English/7963951-cvs-health-tobacco-free-campus

The Tobacco-Free Generation Campus Initiative is part of Be The First, CVS Health’s five-year, $50 million initiative that supports education, advocacy, tobacco control, and healthy behavior programming to help deliver the nation’s first tobacco-free generation. CVS Health has set actionable and measurable goals for Be The First, including a doubling of the number of tobacco-free college and university campuses in the United States.

“With our partners at CVS Health, we are excited to support the efforts of many dedicated students, faculty and staff to make their campuses smoke- and tobacco-free using proven strategies that will also reduce tobacco use among students,” said Gary M. Reedy, Chief Executive Officer for the American Cancer Society. “To be successful in creating a tobacco-free generation, it is important that we prevent and eliminate lethal and addictive tobacco use among college students.”

The American Cancer Society Great American Smokeout will take place on Thursday, November 17. The annual intervention effort encourages smokers to quit for a day, quit for good, or make a plan to quit, and raises awareness around the many tools and resources they can use to help them quit.

Grant Recipients from Coast to Coast

Over the next three years, the Tobacco-Free Generation Campus Initiative will award grants to a total of 125 colleges and universities throughout the U.S. with the greatest need for stronger tobacco prevention and control. The grants will help schools successfully advocate for, adopt and implement 100 percent smoke- and tobacco-free campus policies. Campuses will also receive technical assistance and resources to support their efforts with education, communications, cessation, and evaluation.

The University of Pennsylvania is one of the first 20 grant recipients, and is working towards becoming the first Ivy League institution to adopt a 100 percent tobacco-free campus policy.

“We are grateful to be among the recipients of the American Cancer Society/CVS Health Foundation tobacco control grant as it recognizes and supports Penn’scommitment to a tobacco-free campus,” said Penn President Amy Gutmann. “Under the leadership of Penn pulmonologist Frank Leone, we have developed an innovative, interdisciplinary approach to smoking cessation that has yielded unprecedented success in just two years. Frank Leone and his colleagues understand the complexity of the problem of tobacco dependence and the need to take a long-term view to change tobacco behaviors. This generous grant will greatly aid the University’s ongoing efforts to effectively address this major public health epidemic.”

Other grant recipients include: Bowling Green State University (Ohio), California State University San Marcos, Davenport University (Mich.), East Carolina University (N.C.), El Paso Community College (Texas), Indiana University Bloomington, Lenoir-Rhyne University (N.C.), Merritt College (Calif.), Montclair State University (N.J.), Oakland University (Mich.), Penn State University (Pa.), Piedmont Community College (N.C.), Saint Mary’s College of California, Springfield College (Mass.), St. Xavier University(Ill.), Texas Christian University, Texas A&M University – Corpus Christi, University of Cincinnati Blue Ash College (Ohio) and University of Michigan.

Public Support for Tobacco Control on Campus

TFGCI grants are intended to address a critical, unmet need by supporting efforts to advocate for, establish and institute smoke- and tobacco-free campus policies. The U.S. Department of Education reports there are approximately 4,700 institutions of higher education in the United States. According to the Americans for Nonsmokers’ Rights Foundation, only 1,427 campuses are 100-percent smoke- and tobacco-free. That reflects major progress over earlier years, but much remains to be done.

According to a new national Morning Consult poll of 2,202 registered voters commissioned by CVS Health on October 12-18 2016, there is strong public support for addressing the continued impact of tobacco use on college and university campuses. Among the key poll findings:

  • Seventy-six-percent of Americans think youth smoking and/or tobacco use is a problem. Similarly, 69% of Americans think college student smoking and/or tobacco use is a problem.
  • More than half of Americans (56%) think the number of tobacco-free campuses is too low. This is similar among U.S. college students where the combined percentage is 54 percent.
  • Three-quarters (75%) of Americans support policies that prohibit smoking and other tobacco use on college campuses.
  • Fifty-two percent of Americans think whether or not a campus is tobacco-free is an important consideration when applying to, and potentially attending, a college/university, ranking behind academic quality (86%) and quality of housing (79%), but ahead of how competitive athletic teams are (38%).

“We’re at a critical moment in our nation’s efforts to end the epidemic of smoking and tobacco use, and expanding the number of tobacco-free college and university campuses is an important step in our efforts,” said Troyen A. Brennan, M.D., M.P.H., and Chief Medical Officer for CVS Health. “We’re confident our strategy will drive a significant decline in the number of new college-age smokers, and contribute to the progress being made where a tobacco-free generation in the U.S. seems possible.”

Accepting Applications for New Grants

In partnership with the CVS Health Foundation, the American Cancer Society will begin accepting online applications for the next round of Tobacco-Free Generation Initiative (TFGCI) grants. The fall grant cycle will run through February 28, 2017 with the names of grant recipients to be announced in May 2017.

In addition to grants, colleges and universities will receive technical assistance throughout the tobacco-free policy planning and implementation process. Technical assistance will be provided through webinars, online resources and limited one-on-one consultations.

To learn more about the Tobacco-Free Generation Campus Initiative (TFGCI), U.S. colleges and universities are encouraged to visit www.CVSHealth.com/tobaccofreecampus. To apply for a TFGCI grant, visit www.cancer.org/tfgci.

About The American Cancer Society
The American Cancer Society is a global grassroots force of 2 million volunteers saving lives in every community. As the largest voluntary health organization, the Society’s efforts have contributed to a 23 percent decline in cancer death rates in the U.S. since 1991, and a 50 percent drop in smoking rates. We’re finding cures as the nation’s largest private, not-for-profit investor in cancer research, ensuring people facing cancer have the help they need and continuing the fight for access to quality health care, lifesaving screenings and more. For more information, to get help, or to join the fight, call us anytime, day or night, at (800) 227-2345 or visit cancer.org.

About the CVS Health Foundation
The CVS Health Foundation is a private charitable organization created by CVS Health (NYSE:CVS) that works to build healthier communities, enabling people of all ages to lead healthy, productive lives. The Foundation provides strategic investments to nonprofit partners throughout the U.S. who help increase community-based access to health care for underserved populations, create innovative approaches to chronic disease management and provide tobacco cessation and youth prevention programming. We also invest in scholarship programs that open the pathways to careers in pharmacy to support the academic aspirations of the best and brightest talent in the industry. Our philanthropy also extends to supporting our colleagues’ spirit of volunteerism through Volunteer Challenge grants to nonprofits where they donate their time and fundraising efforts. To learn more about the CVS Health Foundation and its giving, visit www.cvshealth.com/social-responsibility.

FOR MORE INFORMATION, CONTACT:
American Cancer Society:
Charaighn Sesock
559.972.4877
charaighn.sesock@cancer.org

CVS Health:
Joe Goode
401.770.9820
jlgoode@cvs.com

SOURCE: CVS Health

Posted on by

ScriptSync now available at CVS Caremark Mail Service Pharmacy as the service marks its 1st birthday

WOONSOCKET, R.I., 2016-Sep-16 — /EPR Retail News/ — CVS Health (NYSE: CVS) launched ScriptSync , a pharmacy service that prepares patients’ eligible prescription medications so they’re ready for pickup on the same day each month, at all of the company’s retail pharmacy locations just over one year ago. In the past year, more than one million patients have been enrolled in ScriptSync at CVS Pharmacy and preliminary results demonstrate that the service, on average, improves medication adherence by between five to 10 percent. In addition, ScriptSync is now available at CVS Caremark Mail Service Pharmacy, making CVS Health the first national pharmacy provider to offer this type of service in retail and mail pharmacy channels.

“We are focused on helping patients save time while making it easier for them to take all of their medications as prescribed,” said Troyen A. Brennan, M.D., executive vice president and Chief Medical Officer of CVS Health. “With ScriptSync we can remove some of the biggest barriers to medication adherence, such as remembering to refill prescriptions and making multiple pharmacy trips each month. By aligning a patient’s prescription pickup schedule, we can improve convenience and drive adherence, and based on the high enrollment in ScriptSync, it is clear that our patients value this service.”

With the expansion of ScriptSync to CVS Caremark Mail Service Pharmacy, plan members will be able to align their refills and have all maintenance medications delivered together by mail. ScriptSync has already been available to CVS Caremark members who fill prescriptions at any CVS Pharmacy. In fact, nearly 30 percent of those enrolled in ScriptSync at retail are CVS Caremark members.

“At CVS Health, our goal is to deliver solutions that help improve health and lower costs for our customers, clients and members,” added Jonathan Roberts, executive vice president of CVS Health and President of CVS Caremark, the pharmacy benefits manager (PBM) of CVS Health. “Improving medication adherence is a major priority for our PBM clients and a seemingly small enhancement like aligning prescriptions for delivery or once monthly pick up can make a tremendous difference for patients in convenience and outcomes.”

Preliminary results, which tracked enrolled patients’ average days with medication per month using pharmacy claims data, show that ScriptSync improves medication adherence. In addition, patients also report satisfaction with the service. Previously published research from the CVS Health Research Institute found that patients with multiple medications who align their medication refills were more likely to be adherent than patients who made numerous trips to the pharmacy.

Currently, CVS Pharmacy patients with multiple maintenance medications can sign-up for ScriptSync and work with their pharmacy team to identify which prescriptions to include and select a pickup date. Patients can opt to receive a call or text message when their order is ready. In addition, once enrolled, patients or their caregivers can manage their ScriptSync prescriptions 24/7 online at www.CVS.com/ScriptSync and soon patients will be able to manage their ScriptSync prescriptions via the CVS Pharmacy mobile app. There, patients can add or remove prescriptions, check the status of an order and modify their ScriptSync pickup date as needed.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contacts:
Christine Cramer
CVS Health
(401) 770-3317
christine.cramer@cvshealth.com

SOURCE: CVS Health

Posted on by

CVS Health rolls out its annual free health services campaign, Project Health

 

CVS Health rolls out its annual free health services campaign, Project Health CVS Health rolls out its annual free health services campaign, Project Health

 

WOONSOCKET, R.I., 2016-Sep-08 — /EPR Retail News/ — In its continuing commitment to help improve access to health care for all Americans, CVS Health (NYSE: CVS) today (September 7, 2016) announced the rollout of Project Health, its annual free health services campaign, at select CVS Pharmacy locations in 10 multicultural communities across the country. Beginning Thursday, September 8 and running through December 18, nearly $8 million worth of free health services will be delivered at more than 500 Project Health events.

Since 2006, Project Health has delivered more than $112 million worth of free health care services to nearly 872,000 people, many of whom are uninsured or under insured, demonstrating the continuing need for these critical services.

“Despite the increased number of Americans who have become insured over the past five years, there are still barriers to quality care, such as cost and access, for many patients,” said Troyen A. Brennan, M.D., M.P.H., Chief Medical Officer of CVS Health. “Project Health is part of CVS Health’s commitment to improving access to quality care by identifying health concerns and risk factors for participants who may not have otherwise sought preventative care.”

Project Health offers an array of free comprehensive health risk assessments, including blood pressure, Body Mass Index (BMI), glucose and total cholesterol screenings. Once screened, CVS Pharmacy helps patients through on-site consultations with bilingual (English/Spanish) nurse practitioners or physician assistants who will analyze results and refer patients who require additional medical attention to no-cost or low-cost medical facilities nearby or to their primary care physician. CVS pharmacists are also available to conduct one-on-one medication reviews and answer any questions patients may have.

“The Centers for Medicare & Medicaid Services (CMS) applauds CVS Health on their Project Health initiative,” said Kevin Counihan, Director and Marketplace Chief Executive Officer at the Centers for Medicare & Medicaid Services. “We thank them for their continued commitment to providing free health screenings and educational materials ensuring better health for many Americans.”

Over the past 10 years, high rates of certain treatable conditions among Project Health participants have been identified, including:

  • 53 percent were found to be overweight or obese
  • 38 percent had abnormal blood pressure readings
  • 26 percent had abnormal glucose readings
  • 37 percent were found to have abnormal cholesterol levels

Project Health events, held in markets with large multicultural populations, are open to all consumers regardless of race, gender or insurance status and do not require an appointment. Current locations include Atlanta, Chicago, Dallas/Fort Worth, Detroit,Houston, Los Angeles, Miami, New York City, Philadelphia and Washington, D.C.Project Health events are also being held at select CVS Pharmacy stores in Puerto Rico through November on Saturdays and Sundays from 12 p.m. 4 p.m.

U.S. Project Health events will be held from 2 p.m. 6 p.m. on Thursdays, Fridays, Saturdays and Sundays at select CVS Pharmacy locations, with no appointment needed. For a full calendar of Project Health events, visit www.cvs.com/projecthealth(in Spanish: www.cvs.com/proyectosalud).

About CVS Health
CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Mary Alfieri
Mary.Alfieri@CVSHealth.com
401-770-9811

SOURCE: CVS Health

###

Posted on by

CVS Health Research Institute study finds that home infusion care is safe and improves quality of life while reducing health care costs

WOONSOCKET, R.I.,, 2016-May-05 — /EPR Retail News/ — A new study by the CVS Health Research Institute found that home infusion care is safe, clinically effective and improves quality of life while reducing health care costs when compared to infusion care delivered in a hospital or clinic. The findings underscore the value of home infusion services where medication is delivered intravenously in a patient’s home for the health care system, including patients and payers. The study was published in Healthcare: The Journal of Delivery Science and Innovation.

“As the U.S. health care payment system shifts from volume to value, we are focused on identifying new approaches to health service delivery that provide better care and improve patient outcomes while lowering costs,” said Troyen A. Brennan, MD, study author and Chief Medical Officer, CVS Health. “Our research shows that home infusion care is a promising model that is both cost- and clinically-effective and is overwhelmingly preferred by patients when intravenous therapy is required.”

 

Researchers conducted a systematic review of existing peer-reviewed research evaluating infusion care for several conditions, including cystic fibrosis, antibiotics following orthopedic surgery and several cancers requiring infused chemotherapies. Researchers compared measures of quality, safety, clinical outcomes, quality of life and costs of home infusion services to those provided in medical settings. The research showed that patients receiving intravenous therapy at home had as good or better clinical outcomes as those patients who received the same therapy in a traditional health care setting.

In addition, patients overwhelmingly preferred receiving their infusion therapies at home, reporting fewer disruptions in personal schedules and responsibilities. The costs associated with home infusion were also consistently lower than services provided in a health care facility, with savings ranging between $1,928 and $2,974 per course of treatment.

“At CVS Health, we provide important home infusion services to patients through Coram, which is just one of the ways we are expanding our clinical delivery model and helping to move important health services to lower cost sites of care,” added Alan Lotvin, MD, Executive Vice President, CVS Specialty. “In fact, our patients report high satisfaction with our Coram home infusion services, citing convenience and comfort as key elements that improved their overall experience.”

Home infusion services are a rapidly growing delivery model in the health care system with rising rates of chronic and acute conditions that require intravenous therapy. Despite this, clinical outcomes and quality of care have not previously been systematically evaluated. While many commercial health plans provide comprehensive coverage for home infusion services, Medicare has limited reimbursement for this type of care, and Congress is discussing how to implement a comprehensive home infusion benefit for Medicare beneficiaries.

Coram, a service provided by CVS Health, provides vital infusion care and support to tens of thousands of Americans each month with a range of conditions including immune deficiencies, rheumatoid arthritis and serious infections requiring intravenous antibiotic therapy. Care is administered by experienced infusion nurses and pharmacists, and in addition, patients receive additional disease management education and support throughout their treatment.

The CVS Health Research Institute is focused on contributing to the body of scientific knowledge related to pharmacy and health care through research collaborations with external academic institutions, participation in federally-funded research, analysis and sharing of CVS Health data sources and coordination of pilot programs and initiatives. CVS Health Research Institute findings support a continuous quality improvement environment, which encourages product innovation and development to benefit CVS Health patients, clients and their members.

About CVS Health

CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contacts:

Christine Cramer
CVS Health
(401) 770-3317
christine.cramer@cvshealth.com

Christina Beckerman
CVS Health
(401) 770-8868
christina.beckerman@cvshealth.com

CVS Health
One CVS Drive
Woonsocket, Rhode Island 02895

SOURCE CVS Health

Posted on by

CVS Health expands its services across the country through clinical collaborations with leading health care providers

CVS/pharmacy and MinuteClinic clinical collaborations will increase access to care and help improve medication adherence for patients throughout the country

Woonsocket, RI, 2016-Jan-14 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today it has entered into new clinical affiliations with four leading health care providers, John Muir Health in California; University of Chicago Medical Center in Illinois; Novant Health, serving the Winston-Salem area, in North Carolina; and University of Michigan Health System in Michigan. These affiliations will help enhance access to high-quality, affordable health care services for patients. Through these clinical affiliations, CVS Health will provide prescription and visit information to the participating health care organizations by enabling communication between our secured electronic health record (EHR) systems, which will help enhance clinical care for patients. In addition, patients will continue to have access to clinical support, medication counseling, chronic disease monitoring and wellness programs at CVS/pharmacy stores and MinuteClinic, the retail medical clinic of CVS Health.

“We are pleased to work with these exceptional health care providers throughout the country to develop collaborative programs that enhance access to patient care, improve health outcomes and lower health care costs in the communities they serve,” said Troyen A. Brennan, MD, Chief Medical Officer, CVS Health. “By allowing our electronic health records and information systems to communicate and share important information about the patients we collectively serve, we will have a more comprehensive view of our patients, which can aid in health care decision making and help ensure patients adhere to important medications for chronic diseases.”

CVS/pharmacy currently has more than 9,500 retail pharmacy locations across the U.S. where CVS pharmacists provide counseling to patients to help them be adherent to their chronic disease medications. In addition, MinuteClinic also plays an important role by providing patients with timely, affordable and high-quality walk-in health care. MinuteClinic locations are open seven days a week, offering evening hours with no appointment necessary and most health insurance is accepted. The clinics are staffed by nurse practitioners and/or physician assistants who provide treatment for common illnesses and administer wellness and prevention services, including health-condition monitoring for patients with chronic diseases.

Health care providers at participating affiliates will receive data on interventions conducted by CVS pharmacists to improve medication adherence for their patients. The affiliation also encourages collaboration between the health care providers and MinuteClinic providers to improve coordination of care for patients seen at MinuteClinic locations. Through this collaboration, the affiliate organizations and MinuteClinic practitioners will also work together on planning strategies around chronic care and wellness. If more comprehensive care is needed, patients can follow up with their primary care provider and have access to affiliates’ services as appropriate. For those patients who do not have regular access to health care, MinuteClinic provides information to help patients in finding a primary care physician and a greater opportunity for continuity of health care services.

MinuteClinic, CVS/pharmacy and the participating health care providers will begin to work toward streamlining and enabling communication through their EHR systems. This will include the electronic sharing of messages and alerts from CVS/pharmacy to affiliates’ physicians regarding medication non-adherence issues. In addition, MinuteClinic will electronically share patient visit summaries with the patient’s primary care physician when they are part of an affiliate organization and with the patient’s consent. MinuteClinic will continue its standard practice of sending patient visit summaries to primary care providers who are not affiliated with these participating health care organizations via fax or mail, with patient consent.

The new affiliations announced here bring the total number of clinical collaborations for CVS Health and MinuteClinic to nearly 70 major health systems and health care providers across the country.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,500 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Christina Beckerman
CVS Health
(401) 770-8868
christina.beckerman@cvshealth.com

SOURCE: CVS Health